- June 2022
- Use of a trademark by an online service provider: AG Szpunar’s opinion in the Louboutin/Amazon case
- Tightening up the enforcement of sanctions in the EU: the European Commission’s proposal to add sanctions evasion to the list of EU crimes
- May 2022
- The EU General Court confirms the need for arbitration awards to comply with Section 101 and 102 TFEU
- The supremacy of EU law and the European Court of Justice and its effects on the binding nature of a definitive judgement on jurisdiction
- EPPO’s annual report: Figures and perspectives
- Access to judicial records and data protection in Italian law
- April 2022
- The debate goes on: The Italian Supreme Court ruling on the use of opinion polls and surveys in trademark proceedings
- March 2022
- Compensation for unlawful processing of personal data: The use and possible negative consequences of presumptive evidence
- Likes on Facebook posts: How they are viewed by criminal courts
- Arbitration and the metaverse
- February 2022
- Italian Court of Cassation clarifies criteria to determine legal effects of anti-competitive agreements on downstream contracts
- Italian Administrative Court annuls AGCM decision granting damages claimant access to the investigation file
- December 2021
- A first (big) step toward reshaping Italian civil proceedings
- Italian legislative reform: The groundbreaking choice to bet on (international) arbitration
- Coming reform of corporate criminal liability in Italy in an international context: Will there be DPAs?
- EU member states may allow consumer protection associations to bring representative actions for infringement of personal data protection
- The long-awaited revision of the regulation on external communication records in criminal proceedings
- October 2021
- Judicial compensation of non-pecuniary damages and its impact on legal risk management: The latest view from the Italian Supreme Court
- ECJ Sumal judgment: How far may the concept of an “undertaking” extend liability under EU competition law?
- Pharmaceutical company liability in clinical trials: The italian supreme court’s latest decision